Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Involvement of clinicians, including primary care physicians, endocrinologists, and rheumatologists, as appropriate, can ensure a comprehensive and personalized approach to managing osteoporosis and ...